Therefore, combining surgery with pills creates a stronger weight loss plan
Leyden J, Stephens T, Finkey MB, Appa Y, Barkovic S
Larazotide is a peptide designed specifically to address intestinal permeability, commonly known as leaky gut. This condition occurs when the tight junctions in the intestinal lining loosen, allowing toxins, pathogens, and undigested food particles to escape into the bloodstream
It is FDA-approved, widely available, and produces roughly 30-50% more weight loss than semaglutide in clinical trials
Its nausea rate (25%) is marginally lower than Retatrutide (28%), and its overall discontinuation rate due to side effects is about 6% compared to 7% for Retatrutide in Phase 2 data